Second-line treatment of metastatic colorectal cancer with HR070803 in combination with 5-FU/LV and BP102
Ontology highlight
ABSTRACT: Interventions: experimental group:HR0708035, FU/LV and BP102
Primary outcome(s): Objective response rate
Study Design: Single arm
DISEASE(S): Colorectal Cancer
PROVIDER: 113472 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA